Lawyers for the Lifecycle of Foods, Dietary Supplements, Cosmetics, Drugs & Medical Devices
FTC Issues Proposed Rule and Announces Possible Additional Rulemaking to Deter Deceptive Claims by Multi-Level Marketers
On January 13, 2025, the FTC issued a Notice of Proposed Rulemaking (NPRM) for a new Earnings Claim Rule Regarding Multi-Level Marketing (MLM). In the NPRM, the FTC asserts that “[t]he vast majority of MLM MORE >
see all news >Food, Beverage, Dietary Supplement & Cosmetic Compliance
We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness.
MOREIntellectual Property Protection
Drawing heavily on our IP, patent, trade secret, and trademark expertise, we provide our clients with business advice and strategies that enhance product value and prevent future litigation.
MORETrial Practice, Litigation & Dispute Resolution
We have a strong track record in disputes related to FDA, FTC, Proposition 65, consumer false advertising class actions, patent & trademark infringement, supply chain, technology, software, e-commerce and breach of contract claims.
MOREMedical Device & Drug Compliance
We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.
MORE-
news
Amin Wasserman Gurnani Named in Best Lawyers 2025 Guide
Amin Wasserman Gurnani is proud to announce that it has been named to Best Lawyers – “Best Law Firms.”
-
news
New FDA Guidance on Use of Electronic Systems, Records and Signatures in Clinical Investigations
This month, the U.S. Food and Drug Administration (FDA) issued a new broad-reaching guidance document for clinical investigation sponsors, clinical investigators, institutional review boards (IRB), contract research organizations (CRO), and other interested parties on the use of electronic systems, electronic records, and electronic signatures in clinical investigations. See FDA guidance document entitled “Electronic Systems, Electronic […]
-
news
Ivan Wasserman Quoted in “Bill Would Make Big Change to GRAS System”
Ivan Wasserman discussed a new bill before Congress that would change how companies bring new ingredients to market in the Oct. 4 issue of SupplySide Supplement Journal.
Contact
5185 MacArthur Blvd NW
Suite 230
Washington, D.C. 20016
PH:202.496.4966
515 South Flower Street
18th Floor
Los Angeles, CA 90071
PH:213.933.2330
Copyright 2026 by Amin Wasserman Gurnani, LLP | Privacy Statement | Terms Of Use
The content in the Amin Wasserman Gurnani web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Wasserman Gurnani or as the rendering of legal advice for any specific matter.
